Clinical context
This patient is exhibiting a classic
anaphylactic reaction to the first dose of an IV antibiotic: generalized urticaria, upper-airway compromise (hoarseness), bronchospasm (wheezing), and hypotension. The infusion has already been stopped and help summoned, which are correct immediate actions. The next priority is prompt administration of
intramuscular epinephrine into the
anterolateral thigh, as epinephrine is the only first-line medication for anaphylaxis
[2].
Dose calculation
The standard weight-based adult dose for IM epinephrine in anaphylaxis is
0.01 mg/kg, with an adult maximum of
0.5 mg [1][3]. For this patient weighing
80 kg, the calculated dose would be 0.01 × 80 =
0.8 mg. However, because 0.8 mg exceeds the adult ceiling of
0.5 mg, the dose is capped at
0.5 mg. With a concentration of
1 mg/mL, the volume to administer is
0.5 mL.
The adult maximum of 0.5 mg takes precedence over the calculated weight-based dose whenever the patient's weight would push the dose above that ceiling. This is a deliberate safety limit because higher IM doses have not been shown to improve outcomes and may increase adverse effects
[3].
Why the 0.5 mg cap matters in this patient
This patient is already taking
metoprolol, a beta-blocker, for hypertension. Beta-blockade can blunt the response to epinephrine and may contribute to refractory hypotension and bradycardia during anaphylaxis. However, the presence of beta-blocker therapy does not change the initial IM epinephrine dose; the same
0.01 mg/kg (maximum
0.5 mg) is used. What it does change is the expectation that additional interventions—such as IV fluids, oxygen, and possibly glucagon if hypotension persists—may be needed
[2][4]. The nurse should anticipate that this patient may require more aggressive supportive care than a patient not on beta-blockers.
Watch out! Do not confuse the
0.3 mg dose commonly found on epinephrine auto-injectors with the weight-based hospital dose. The
0.3 mg auto-injector is a fixed dose intended for patients roughly
30 kg and above in the community setting, but in the hospital, the weight-based calculation with the
0.5 mg maximum is preferred
[1][3]. For an
80 kg adult,
0.3 mg would be an under-dose.
Key point! The correct answer is
0.5 mL, not
0.8 mL, because the adult maximum dose overrides the weight-based calculation. The nurse must recognize that
the maximum single IM dose for an adult is 0.5 mg, regardless of body weight above 50 kg [1].
Clinical implications of under-dosing
Retrospective data suggest that using
0.3 mg instead of
0.5 mg in adults weighing more than
50 kg may be associated with a higher incidence of escalation of care, such as additional epinephrine doses, ICU admission, or intubation
[1]. This reinforces the importance of calculating the weight-based dose and using the full
0.5 mg when indicated, rather than defaulting to the auto-injector dose.
Nursing actions after epinephrine
After the IM epinephrine is given, the nurse should place the patient supine with the legs elevated to support venous return and cerebral perfusion
[4]. High-flow oxygen and rapid infusion of crystalloid fluids are also indicated to address hypoxemia and distributive shock
[4]. Vital signs and airway status must be reassessed frequently, and a second dose of IM epinephrine may be repeated every
5–15 minutes if symptoms persist
[2]. Because this patient is on metoprolol, the team should be prepared for the possibility of epinephrine-resistant hypotension and consider adjuncts such as IV glucagon
[2].
References (research sources)
- [1]
Retrospective comparison between 0.3 mg and 0.5 mg dosing of intramuscular epinephrine for anaphylaxis.Research articleJackson CA, Dillon RC, Fleenor LM, Pauw EK, O'Keefe MM (2026) · DOI: 10.1016/j.ajem.2025.10.020
- [2]
Epinephrine in the Management of Anaphylaxis.Research articleBrown JC, Simons E, Rudders SA (2020) · DOI: 10.1016/j.jaip.2019.12.015
- [3]
Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.Research articleBrown JC (2018) · DOI: 10.1016/j.anai.2018.05.001
- [4]
[Anaphylaxis].Research articleMalling HJ, Hansen KS, Garvey LH (2014)